Alongside its results, the company announced a significant product launch. On August 11, Pfizer rolled out its ...

A next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new ...

Pfizer's revenue grew 7.1% to ₹604 crore from ₹563 crore, while EBITDA increased 18.1% to ₹209.7 crore from ₹177.6 crore in ...

Pfizer’s PCV20 offers single-shot protection against 20 pneumococcal serotypes, safeguarding adults from serious respiratory ...

Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

Indian equity benchmarks closed lower in a volatile Tuesday session, weighed down by blue-chip bank stocks and caution ahead ...

Indian equity markets opened on a cautious note, a day after recording a sharp recovery that snapped a six-week losing streak ...

Indian equity markets closed in the green on Monday, boosted by gains by state-run banks, and real estate stocks in ...

Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes, including both invasive and non ...